Christopher Davitt

Christopher Davitt, PhD, currently serves as the Director of Partnerships and Commercial Strategy at Farcast Biodynamics since March 2024. Previously, Christopher held various positions at BostonGene from January 2022 to March 2024, including Associate Director of Business Development and Alliance Management. Prior experience includes roles as Principal Scientist at DeepCure and Senior Scientist in Immunology at GreenLight Biosciences, as well as significant contributions to the field of immunology during tenures at Evelo Biosciences, Tulane University, and Trinity College Dublin. Academic credentials include a PhD in Oral Vaccination, Enteric Diseases and Mucosal Immunology from Trinity College Dublin, complemented by a Professional Diploma in International Business Studies. Christopher has demonstrated extensive expertise in immune assays, vaccine development, and strategic partnership cultivation throughout a diverse career in both research and business development.